PROSTATE CANCER CASTRATION-RESISTANT PROSTATE CANCER
Clinical trials for PROSTATE CANCER CASTRATION-RESISTANT PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new PROSTATE CANCER CASTRATION-RESISTANT PROSTATE CANCER trials appear
Sign up with your email to follow new studies for PROSTATE CANCER CASTRATION-RESISTANT PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Antibody-Drug conjugate targets Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new drug called MBRC-201 in people with advanced solid tumors (like prostate, breast, lung, colorectal, or pancreatic cancer) that have not responded to standard therapies. The drug is an antibody-drug conjugate, designed to deliver a cancer-killing agent direc…
Matched conditions: PROSTATE CANCER CASTRATION-RESISTANT PROSTATE CANCER
Phase: PHASE1, PHASE2 • Sponsor: MBrace Therapeutics • Aim: Disease control
Last updated May 26, 2026 03:20 UTC
-
Engineered immune cells take on Hard-to-Treat prostate cancer
Disease control Recruiting nowThis early-phase trial tests a new cell therapy called Anti-PSMA CAR NK cells in 10 people with metastatic castration-resistant prostate cancer (mCRPC). The goal is to see if the treatment is safe and can slow the cancer. Participants must have a specific marker (PSMA) on their c…
Matched conditions: PROSTATE CANCER CASTRATION-RESISTANT PROSTATE CANCER
Phase: EARLY_PHASE1 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 26, 2026 03:04 UTC
-
Engineered immune cells take aim at Hard-to-Treat prostate cancer
Disease control Recruiting nowThis study tests a new treatment for men with advanced prostate cancer that has stopped responding to standard hormone therapy. The treatment uses specially designed immune cells (called CAR-NK cells) that are trained to find and attack prostate cancer cells. The main goals are t…
Matched conditions: PROSTATE CANCER CASTRATION-RESISTANT PROSTATE CANCER
Phase: EARLY_PHASE1 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 20, 2026 11:57 UTC